Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto University, 1-1-1, Honjo, Chuo-ku, Kumamoto, 860-8556, Japan.
International Research Center for Medical Sciences (IRCMS), Kumamoto University, Kumamoto, Japan.
Heart Vessels. 2022 Jun;37(6):911-918. doi: 10.1007/s00380-021-01997-7. Epub 2022 Jan 11.
Cardiovascular and cerebrovascular diseases are considered the principal cause of morbidity and mortality worldwide; the effect of stroke-induced cardiac manifestations is well recognized; however, not enough clinical data have been found about the impact of stroke with underlying cardiac disease. This study's objective is to assess the impact of stroke on the prognosis of patients with underlying IHD, who underwent PCI treatment. This was a multicenter, 1-year observational study in patients undergoing PCI in one of the 17 participating centers across Japan. 18,495 patients were registered on the PCI list; 2481 patients had a prior stroke experience, whereas 15,979 were stroke-free. Our study revealed that stroke patients were significantly older (mean age 73.5 ± 9.6, 69.7(± 11.5), respectively), and suffered from more comorbidities (diabetes, hypertension, and chronic kidney disease, p < 0.0001). During the 1-year period, subjects with stroke showed higher incidence of clinical events compared to those without stroke; to illustrate, all-cause death accounted for 6.2% in patients with stroke, in contrast to only 2.8% in stroke-free patients (p < 0.0001), cardiac death amounted for 2.2 and 1.2%, respectively (p < 0.0001), recurrent stroke for 3.1% and 1.2% (p < 0.0001), non-cardiac death for 3.6 and 1.54% (p < 0.0001), and finally, hemorrhagic complications with 2.6 and 1.3% (p < 0.0001). Kaplan-Meier analysis revealed that stroke patients had a higher probability of all-cause mortality, cardiac death, and recurrent stroke (log-rank p < 0.0001). Cox hazard analysis also showed that the presence of stroke is a significant indicator in determining the outcome of cardiac death (HR = 1.457, 95% CI 1.036-2.051, p = 0.031); hence, proving it to be a crucial predictor on cardiac prognosis. History of prior stroke was common in PCI patients, and independently associated with a higher rate of subsequent cardiovascular and cerebrovascular events recurrence. Thus, highlighting an urgent need for comprehensive prevention of cardiac and cerebrovascular diseases.
心脑血管疾病被认为是全球发病率和死亡率的主要原因;中风引起的心脏表现的影响已得到充分认识;然而,关于潜在心脏病患者中风的影响,尚未发现足够的临床数据。本研究旨在评估中风对接受 PCI 治疗的潜在 IHD 患者预后的影响。这是一项在日本 17 个参与中心之一进行的多中心、为期 1 年的 PCI 患者观察研究。18495 名患者在 PCI 名单上登记;2481 名患者有中风史,而 15979 名患者无中风史。我们的研究表明,中风患者年龄明显较大(平均年龄 73.5 ± 9.6,69.7(±11.5),分别),并患有更多的合并症(糖尿病、高血压和慢性肾病,p<0.0001)。在 1 年期间,与无中风患者相比,中风患者发生临床事件的发生率更高;具体来说,中风患者的全因死亡率为 6.2%,而无中风患者的死亡率仅为 2.8%(p<0.0001),心源性死亡率分别为 2.2%和 1.2%(p<0.0001),复发性中风为 3.1%和 1.2%(p<0.0001),非心源性死亡为 3.6%和 1.54%(p<0.0001),最后,出血并发症为 2.6%和 1.3%(p<0.0001)。Kaplan-Meier 分析显示,中风患者全因死亡率、心源性死亡率和复发性中风的概率更高(对数秩 p<0.0001)。Cox 风险分析还表明,中风的存在是确定心源性死亡结果的一个重要指标(HR=1.457,95%CI 1.036-2.051,p=0.031);因此,证明它是心脏预后的一个关键预测因素。既往中风史在 PCI 患者中很常见,且与随后心血管和脑血管事件复发的发生率增加独立相关。因此,突出了对心脏和脑血管疾病进行全面预防的迫切需要。